HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Bernardi, D. Articles by Plebani, M. Search for Related Content PubMed PubMed Citation Articles by Bernardi, D. Articles by Plebani, M. Related Collections Clinical Immunology Proteomics and Protein Markers

YKL-40 as a Marker of Joint Involvement in Inflammatory Bowel Disease

¹ Department of Laboratory Medicine, University-Hospital of Padua, 35128 Padua, Italy

² Division of Rheumatology, University of Padua, 35128 Padua, Italy

^aaddress correspondence to this author at: Department of Laboratory Medicine, Azienda Ospedaliera di Padova, Via Giustiniani, 2, 35128 Padova, Italy; fax 39-049-663240, e-mail mario.plebani@sanita.padova.it

The first 300 words of the full text of this article appear below.

Rheumatic symptoms are the most common extra-intestinal manifestations of inflammatory bowel diseases (IBD). Both ulcerative colitis and Crohn disease (1)(2) can be complicated by seronegative spondyloarthropathies, including two principal patterns of arthritis: spondylitis and peripheral arthritis. Spondyloarthropathies resembling idiopathic ankylosing spondylitis occur in 10% of patients with ulcerative colitis and, less frequently, in those with Crohn disease; peripheral, often asymmetric, arthropathies occur in 5–20% of IBD patients. Unlike arthropathy limited to five or fewer joints, polyarthropathy and spondyloarthropathies do not reflect the activity of the underlying IBD.

The "gold standard" for assessing joint damage remains the plain radiograph, which images only the bone and allows reliable detection of changes within a time span of at least 12 months. Importantly, all such techniques image only damage that has already occurred. Even after repeated investigations, they are of limited use in informing the clinician of continuing or future damage.

Biochemical markers may provide a valuable tool for the frequent quantitative measurements required for the diagnosis and monitoring of joint disease. Highly sensitive C-reactive protein (CRP) assays provide information on the inflammatory process (3) but are poor markers for joint disease in IBD. Other markers for joint disease have been proposed (4) that are related to structures within joints.

The concentrations of YKL-40 in serum and synovial fluid are closely correlated in patients with joint disease (5), suggesting that most of the protein found in serum may be produced within the joint (6)(7). YKL-40 is produced not only by chondrocytes and synovial cells but also by macrophages, neutrophils, cancer cells, endothelial cells, smooth muscle cells in blood vessels, and by cells (probably hepatic stellate cells) in the fibrotic liver (8)(9)(10)(11)(12. . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				C. E. Pelloski, A. Mahajan, M. Maor, E. L. Chang, S. Woo, M. Gilbert, H. Colman, H. Yang, A. Ledoux, H. Blair, et al. YKL-40 Expression is Associated with Poorer Response to Radiation and Shorter Overall Survival in Glioblastoma Clin. Cancer Res., May 1, 2005; 11(9): 3326 - 3334. [Abstract] [Full Text] [PDF]

				P. B. Liton, X. Liu, W. D. Stamer, P. Challa, D. L. Epstein, and P. Gonzalez Specific Targeting of Gene Expression to a Subset of Human Trabecular Meshwork Cells Using the Chitinase 3-Like 1 Promoter Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 183 - 190. [Abstract] [Full Text] [PDF]